Neola Medical AB (OSTO:NEOLA) EBIT : kr-9.84 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Neola Medical AB EBIT?

Neola Medical AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was kr-2.57 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-9.84 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Neola Medical AB's annualized ROC % for the quarter that ended in Mar. 2024 was -18.03%. Neola Medical AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -8,117.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Neola Medical AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -7.38%.

Neola Medical AB EBIT Historical Data

The historical data trend for Neola Medical AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neola Medical AB EBIT Chart

Neola Medical AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-2.61

-6.72

-6.65

-10.39

-9.63

Neola Medical AB Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-2.36	-2.59	-2.54	-2.15	-2.57

Competitive Comparison of Neola Medical AB's EBIT

For the Medical Devices subindustry, Neola Medical AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neola Medical AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's EV-to-EBIT falls into.

Neola Medical AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.84 Mil.

Neola Medical AB (OSTO:NEOLA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Neola Medical AB's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-10.268 * ( 1 - 0% )	/	( (61.9	+	52.006)	/ 2 )
=	-10.268	/	56.953
=	-18.03 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	86.018	-	2.54	-	( 21.578	-	max(0, 6.157	-	43.105	+	21.578	))
=	61.9

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	83.074	-	0	-	( 35.145	-	max(0, 5.882	-	36.95	+	35.145	))
=	52.006

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Neola Medical AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-10.268	/	( ( (0.137 + max(-5.527, 0))	+	(0.116 + max(-4.077, 0)) )	/	2 )
=	-10.268	/	( ( 0.137	+	0.116 )	/	2 )
=	-10.268	/	0.1265
=	-8,117.00 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.63)	-	(2.54	+	0	+	3.617)
=	-5.527

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.805	+	0	+	0)	-	(0	+	0	+	5.882)
=	-4.077

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Neola Medical AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-9.837	/	133.216
	=	-7.38 %

Neola Medical AB EBIT Related Terms

Thank you for viewing the detailed overview of Neola Medical AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Neola Medical AB (OSTO:NEOLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neola Medical AB (OSTO:NEOLA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevägen 27, Ideon Science Park, Lund, SWE, 223 63

Website

https://www.neolamedical.se

Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.

Neola Medical AB (OSTO:NEOLA) Headlines

No Headlines